Search research articles
Contact Us
Filters
Showing results (161-170 of 228) with videos related to
Page
of 23
Sort By:
Lancet (London, England)
|
August 21, 2003
Proteomic patterns of tumour subsets in non-small-cell lung cancer
Kiyoshi Yanagisawa, Yu Shyr, Baogang J Xu, et al.
American Journal of Respiratory and Critical Care Medicine
|
December 3, 2016
Secretory IgA Deficiency in Individual Small Airways Is Associated with Persistent Inflammation and Remodeling
Vasiliy V Polosukhin, Bradley W Richmond, Rui-Hong Du, et al.
Cancer
|
March 3, 2005
Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma
Eric T Shinohara, Adriana Gonzalez, Pierre P Massion, et al.
Oncogene
|
May 24, 2018
xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression
Xiangming Ji, Jun Qian, S M Jamshedur Rahman, et al.
Chest
|
April 12, 2022
The Association of Health Care System Resources With Lung Cancer Screening Implementation: A Cohort Study
Jennifer A Lewis, Lauren R Samuels, Jason Denton, et al.
Scientific Reports
|
July 14, 2021
HLA-DR cancer cells expression correlates with T cell infiltration and is enriched in lung adenocarcinoma with indolent behavior
Maria-Fernanda Senosain, Yong Zou, Tatiana Novitskaya, et al.
Journal of the American College of Radiology : JACR
|
January 9, 2021
Organizational Readiness for Lung Cancer Screening: A Cross-Sectional Evaluation at a Veterans Affairs Medical Center
Lucy B Spalluto, Jennifer A Lewis, Deonni Stolldorf, et al.
The Journal of Liquid Biopsy
|
August 20, 2025
A multivariate cell-based liquid biopsy for lung nodule risk stratification: Analytical validation and early clinical evaluation
Jason D Berndt, Fergal J Duffy, Mark D D'Ascenzo, et al.
BMC Systems Biology
|
February 26, 2014
Co-expression network analysis identifies Spleen Tyrosine Kinase (SYK) as a candidate oncogenic driver in a subset of small-cell lung cancer
Akshata R Udyavar, Megan D Hoeksema, Jonathan E Clark, et al.
Journal of the National Cancer Institute
|
August 14, 2013
Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer
Daniel Ajona, María J Pajares, Leticia Corrales, et al.
Page
of 23
Search research articles
Search
Showing results (161-170 of 228) with videos related to
Sort By:
Page
of 23
Lancet (London, England)
|
August 21, 2003
Proteomic patterns of tumour subsets in non-small-cell lung cancer
Kiyoshi Yanagisawa, Yu Shyr, Baogang J Xu, et al.
American Journal of Respiratory and Critical Care Medicine
|
December 3, 2016
Secretory IgA Deficiency in Individual Small Airways Is Associated with Persistent Inflammation and Remodeling
Vasiliy V Polosukhin, Bradley W Richmond, Rui-Hong Du, et al.
Cancer
|
March 3, 2005
Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma
Eric T Shinohara, Adriana Gonzalez, Pierre P Massion, et al.
Oncogene
|
May 24, 2018
xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression
Xiangming Ji, Jun Qian, S M Jamshedur Rahman, et al.
Chest
|
April 12, 2022
The Association of Health Care System Resources With Lung Cancer Screening Implementation: A Cohort Study
Jennifer A Lewis, Lauren R Samuels, Jason Denton, et al.
Scientific Reports
|
July 14, 2021
HLA-DR cancer cells expression correlates with T cell infiltration and is enriched in lung adenocarcinoma with indolent behavior
Maria-Fernanda Senosain, Yong Zou, Tatiana Novitskaya, et al.
Journal of the American College of Radiology : JACR
|
January 9, 2021
Organizational Readiness for Lung Cancer Screening: A Cross-Sectional Evaluation at a Veterans Affairs Medical Center
Lucy B Spalluto, Jennifer A Lewis, Deonni Stolldorf, et al.
The Journal of Liquid Biopsy
|
August 20, 2025
A multivariate cell-based liquid biopsy for lung nodule risk stratification: Analytical validation and early clinical evaluation
Jason D Berndt, Fergal J Duffy, Mark D D'Ascenzo, et al.
BMC Systems Biology
|
February 26, 2014
Co-expression network analysis identifies Spleen Tyrosine Kinase (SYK) as a candidate oncogenic driver in a subset of small-cell lung cancer
Akshata R Udyavar, Megan D Hoeksema, Jonathan E Clark, et al.
Journal of the National Cancer Institute
|
August 14, 2013
Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer
Daniel Ajona, María J Pajares, Leticia Corrales, et al.
Page
of 23